Back to Journals » Patient Related Outcome Measures » Volume 5

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life

Total article views   HTML views PDF downloads Totals
20,889 Dovepress* 8,552+ 2,032 10,584
PubMed Central* 12,337 1,244 13,581
Totals 20,889 3,276 24,165
*Since 4 April 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
11 0 0 0 5 6

View citations on PubMed Central and Google Scholar